Evogene (EVGN) Balance Sheet: Assets & Liabilities

Evogene (EVGN) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Evogene reported total assets of $20.05M and total liabilities of $8.07M. Shareholders' equity was negative at −$82.00K, meaning liabilities exceed assets. Total debt stood at $2.20M against $12.96M in cash and short-term investments, a net cash position of $10.76M.

Evogene Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Evogene Ltd. (EVGN) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	12.96	15.30	20.77	28.98	32.33	46.23	34.75	5.81	3.44
Short-Term Investments	0.00	0.01	10.29	6.38	3.00	2.00	12.13	48.66	68.32
Cash & Short-Term Investments	12.96	15.30	31.06	35.36	53.87	48.23	46.88	54.47	71.76
Accounts Receivable	1.38	1.09	0.80	0.80	0.28	2.17	1.21	0.75	0.81
Inventory	0.21	1.82	0.08	0.57	0.09	0.00	0.00	0.00	0.00
Other Current Assets	1.09	2.97	2.53	1.03	1.69	1.38	0.93	0.32	0.27
Total Current Assets	15.63	21.59	34.47	37.75	56.89	51.82	49.03	55.49	72.79
Non-Current Assets
Property, Plant & Equipment (Net)	2.64	4.25	3.44	4.07	4.18	3.94	5.25	3.19	4.79
Long-Term Investments	0.04	0.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	0.00	12.20	13.17	14.14	15.21	16.14	17.07	0.00	0.00
Other Non-Current Assets	1.74	1.75	0.03	0.07	0.03	0.01	0.01	0.02	0.02
Total Non-Current Assets	4.42	18.28	16.63	18.38	19.41	20.09	22.34	3.21	4.81
Total Assets	20.05	39.86	51.10	56.13	76.30	71.92	71.36	58.69	77.60
Current Liabilities
Accounts Payable	0.64	1.23	1.79	1.04	1.46	0.86	1.00	1.01	1.11
Short-Term Debt	0.72	10.37	0.85	1.77	1.95	0.78	0.90	0.00	0.00
Accrued Liabilities	0.86	1.87	2.54	1.99	2.66	2.54	-	-	-
Deferred Revenue	0.07	0.68	0.75	0.10	0.18	0.11	0.42	1.40	0.62
Other Current Liabilities	2.02	2.88	3.56	2.72	1.61	5.39	3.43	3.02	4.10
Total Current Liabilities	3.44	18.70	6.94	5.63	6.88	9.68	5.75	5.43	4.66
Non-Current Liabilities
Long-Term Debt	1.48	1.91	10.65	11.05	1.70	1.66	2.08	0.00	0.00
Other Non-Current Liabilities	0.07	0.09	0.39	0.00	4.31	0.00	0.00	0.03	0.03
Total Non-Current Liabilities	4.63	6.33	15.47	15.71	6.00	5.36	5.40	2.96	3.56
Total Liabilities	8.07	25.03	22.42	21.34	12.88	15.03	11.15	8.39	8.22
Stockholders' Equity
Common Stock	0.49	0.36	0.29	0.24	0.23	0.20	0.14	0.14	0.14
Retained Earnings	-282.56	-274.07	-257.59	-233.71	-207.07	-179.28	-155.90	-137.79	-117.03
Accumulated Other Comprehensive Income	0.00	272.26	269.35	261.40	260.49	225.12	205.90	187.70	372.54
Additional Paid-in Capital	281.99	272.26	0.00	0.00	260.49	0.00	0.00	0.00	0.00
Minority Interest	12.06	16.29	16.63	6.86	9.77	10.84	10.07	0.25	0.00
Shares Outstanding	8.72	6.51	5.06	4.13	4.12	-	-	-	-
Total Stockholders' Equity	-0.08	-1.45	12.05	27.93	63.42	56.88	50.14	50.05	69.38
Total Liabilities & Equity	20.05	39.86	51.10	56.13	76.30	71.92	71.36	58.69	77.60

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Evogene Balance Sheet

How much debt does Evogene have?

Evogene had total debt of $2.20M as of Dec 31, 2025, against $12.96M in cash and short-term investments. Total debt was $12.29M a year earlier.

What are Evogene's total assets?

Evogene reported total assets of $20.05M as of Dec 31, 2025, down 49.7% from $39.86M a year earlier. Total liabilities were $8.07M.

What is Evogene's shareholders' equity?

Evogene's shareholders' equity was negative at −$82.00K as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition